Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
10229 | 1079 | 29.7 | 42% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
658 | 3 | COENZYME Q10//UBIQUINONE//COENZYME Q | 11100 |
2774 | 2 | VINPOCETINE//NEFIRACETAM//PIRACETAM | 3137 |
10229 | 1 | ANIRACETAM//PIRACETAM//OXIRACETAM | 1079 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ANIRACETAM | authKW | 702321 | 4% | 53% | 47 |
2 | PIRACETAM | authKW | 694995 | 7% | 33% | 75 |
3 | OXIRACETAM | authKW | 485664 | 3% | 59% | 29 |
4 | CNS SUPPORTING | address | 339577 | 1% | 100% | 12 |
5 | NOOTROPICS | authKW | 316612 | 4% | 25% | 44 |
6 | SUNIFIRAM | authKW | 229213 | 1% | 90% | 9 |
7 | NOOTROPIC DRUGS | authKW | 195133 | 2% | 34% | 20 |
8 | SABELUZOLE | authKW | 164639 | 1% | 73% | 8 |
9 | COGNITION ENHANCERS | authKW | 159398 | 1% | 43% | 13 |
10 | MOUSE PASSIVE AVOIDANCE TEST | authKW | 141491 | 0% | 100% | 5 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 7700 | 49% | 0% | 532 |
2 | Psychiatry | 2209 | 17% | 0% | 184 |
3 | Neurosciences | 1394 | 23% | 0% | 244 |
4 | Chemistry, Medicinal | 1218 | 11% | 0% | 114 |
5 | Clinical Neurology | 654 | 12% | 0% | 130 |
6 | Geriatrics & Gerontology | 572 | 4% | 0% | 45 |
7 | Behavioral Sciences | 358 | 5% | 0% | 49 |
8 | Medicine, Research & Experimental | 318 | 8% | 0% | 81 |
9 | Psychology | 120 | 3% | 0% | 30 |
10 | Toxicology | 84 | 3% | 0% | 37 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CNS SUPPORTING | 339577 | 1% | 100% | 12 |
2 | SUPPORTING | 31832 | 0% | 38% | 3 |
3 | AD TAT TAURAT FONCTIONNELLES SCI ST | 28298 | 0% | 100% | 1 |
4 | BRANE DISCOVERY | 28298 | 0% | 100% | 1 |
5 | CHAIR NEUROL MANUAL REFLEXOTHER Y | 28298 | 0% | 100% | 1 |
6 | CHAIR NEUROL NEUROSURGCHAIR NEUROL | 28298 | 0% | 100% | 1 |
7 | CHAIR PHYSIOL PATHOL AUDITORY VESTIBULAR SYST | 28298 | 0% | 100% | 1 |
8 | DIPARTIMENTO PHARMACOL PRECLIN CLIN | 28298 | 0% | 100% | 1 |
9 | DIPARTIMENTO SCI CHIMVIALE A DORIA 6 | 28298 | 0% | 100% | 1 |
10 | FARMCATTEDRA CHIM GEN 2 | 28298 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ACTIVITAS NERVOSA SUPERIOR | 21504 | 3% | 3% | 27 |
2 | PHARMACOPSYCHIATRY | 11836 | 3% | 1% | 29 |
3 | DRUG DEVELOPMENT RESEARCH | 11726 | 3% | 1% | 35 |
4 | METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY | 11082 | 3% | 1% | 32 |
5 | FARMAKOLOGIYA I TOKSIKOLOGIYA | 6714 | 2% | 1% | 17 |
6 | BIBLIOTHECA PSYCHIATRICA | 5531 | 0% | 7% | 3 |
7 | REVUE DU CINEMA | 4041 | 0% | 14% | 1 |
8 | PSYCHOPHARMACOLOGY BULLETIN | 4022 | 1% | 1% | 16 |
9 | NEUROPSYCHOBIOLOGY | 3833 | 2% | 1% | 18 |
10 | DRUG INVESTIGATION | 3489 | 1% | 2% | 6 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ANIRACETAM | 702321 | 4% | 53% | 47 | Search ANIRACETAM | Search ANIRACETAM |
2 | PIRACETAM | 694995 | 7% | 33% | 75 | Search PIRACETAM | Search PIRACETAM |
3 | OXIRACETAM | 485664 | 3% | 59% | 29 | Search OXIRACETAM | Search OXIRACETAM |
4 | NOOTROPICS | 316612 | 4% | 25% | 44 | Search NOOTROPICS | Search NOOTROPICS |
5 | SUNIFIRAM | 229213 | 1% | 90% | 9 | Search SUNIFIRAM | Search SUNIFIRAM |
6 | NOOTROPIC DRUGS | 195133 | 2% | 34% | 20 | Search NOOTROPIC+DRUGS | Search NOOTROPIC+DRUGS |
7 | SABELUZOLE | 164639 | 1% | 73% | 8 | Search SABELUZOLE | Search SABELUZOLE |
8 | COGNITION ENHANCERS | 159398 | 1% | 43% | 13 | Search COGNITION+ENHANCERS | Search COGNITION+ENHANCERS |
9 | MOUSE PASSIVE AVOIDANCE TEST | 141491 | 0% | 100% | 5 | Search MOUSE+PASSIVE+AVOIDANCE+TEST | Search MOUSE+PASSIVE+AVOIDANCE+TEST |
10 | CEREBRAL HYPOXIC HYPOXIDOSIS | 113192 | 0% | 100% | 4 | Search CEREBRAL+HYPOXIC+HYPOXIDOSIS | Search CEREBRAL+HYPOXIC+HYPOXIDOSIS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GOULIAEV, AH , SENNING, A , (1994) PIRACETAM AND OTHER STRUCTURALLY RELATED NOOTROPICS.BRAIN RESEARCH REVIEWS. VOL. 19. ISSUE 2. P. 180 -222 | 144 | 67% | 196 |
2 | HITZENBERGER, G , RAMEIS, H , MANIGLEY, C , (1998) PHARMACOLOGICAL PROPERTIES OF PIRACETAM - RATIONALE FOR USE IN STROKE PATIENTS.CNS DRUGS. VOL. 9. ISSUE . P. 19 -27 | 31 | 86% | 13 |
3 | SALETU, B , HITZENBERGER, G , GRUNBERGER, J , ANDERER, P , ZYHLARZ, G , LINZMAYER, L , RAMEIS, H , (1995) DOUBLE-BLIND, PLACEBO-CONTROLLED, PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES WITH 2 NEW FORMULATIONS OF PIRACETAM (INFUSION AND SYRUP) UNDER HYPOXIA IN MAN.INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. VOL. 33. ISSUE 5. P. 249-262 | 33 | 89% | 17 |
4 | GAMZU, ER , HOOVER, TM , GRACON, SI , NINTEMAN, MV , (1989) RECENT DEVELOPMENTS IN 2-PYRROLIDINONE-CONTAINING NOOTROPICS.DRUG DEVELOPMENT RESEARCH. VOL. 18. ISSUE 3. P. 177-189 | 47 | 78% | 33 |
5 | WINBLAD, B , (2005) PIRACETAM: A REVIEW OF PHARMACOLOGICAL PROPERTIES AND CLINICAL USES.CNS DRUG REVIEWS. VOL. 11. ISSUE 2. P. 169-182 | 33 | 56% | 79 |
6 | MONDADORI, C , (1996) NOOTROPICS: PRECLINICAL RESULTS IN THE LIGHT OF CLINICAL EFFECTS; COMPARISON WITH TACRINE.CRITICAL REVIEWS IN NEUROBIOLOGY. VOL. 10. ISSUE 3-4. P. 357-370 | 40 | 69% | 9 |
7 | GOULIAEV, AH , MONSTER, JB , VEDSO, M , SENNING, A , (1995) SYNTHETIC AND ANALYTICAL ASPECTS OF THE CHEMISTRY OF PIRACETAM-TYPE SUBSTITUTED PYRROLIDINES - A REVIEW.ORGANIC PREPARATIONS AND PROCEDURES INTERNATIONAL. VOL. 27. ISSUE 3. P. 273-303 | 52 | 52% | 14 |
8 | GUSEV, EI , BOGOLEPOVA, AN , (2008) EFFECTIVENESS OF NOOTROPIL IN THE TREATMENT OF PATIENTS WITH CEREBRAL STROKE.ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA. VOL. 108. ISSUE 1. P. 82-86 | 25 | 71% | 0 |
9 | FROSTL, W , MAITRE, L , (1989) THE FAMILIES OF COGNITION ENHANCERS.PHARMACOPSYCHIATRY. VOL. 22. ISSUE . P. 54-100 | 134 | 21% | 61 |
10 | CAVOY, A , VANGOLFRACHT, B , DELACOUR, J , (1994) RELATIONSHIPS BETWEEN AROUSAL AND COGNITION-ENHANCING EFFECTS OF OXIRACETAM.PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR. VOL. 47. ISSUE 2. P. 283-287 | 24 | 100% | 1 |
Classes with closest relation at Level 1 |